Skip to content

BBOT - BridgeBio Oncology Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchB

BridgeBio Oncology Therapeutics, Inc.

BBOT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

B

BBOTBridgeBio Oncology Therapeutics, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $14.87
52-wk low: $7.00
Prev close: $12.24
Mkt cap: $769.7M
Beta: 0.36
P/B: 2.2x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$48.8M

CI
Citadel
Ken Griffin · Q2 2026 13F
$19.9M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 11, 2026

Earnings came in 29.1% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $770M

Valuation

P/B2.22

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: BBOT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $769.67M
Beta: 0.36

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-81.9%

$804K

position

BH

Brevan Howard

Alan Howard · Q2 2026 13F

$691K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for BBOT

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.71-29.1%

-$0.55 expected

Next report

What the street expects next

EPS expected

-$0.54

-$0.67 to -$0.41

Revenue expected

$0.00

9 analysts

Last 30 days

0up1down

Analysts cutting estimates

-81.9%

ROA-47.1%

Growth

Beta0.36